Insider Selling: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Director Sells 21,700 Shares of Stock

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director Amy W. Schulman sold 21,700 shares of Alnylam Pharmaceuticals stock in a transaction on Wednesday, May 29th. The stock was sold at an average price of $148.60, for a total value of $3,224,620.00. Following the transaction, the director now directly owns 8,436 shares of the company’s […]

Leave a Reply

Your email address will not be published.

Previous post William E. Brown Sells 700,000 Shares of Central Garden & Pet (NASDAQ:CENTA) Stock
Next post NWK Group Inc. Boosts Holdings in Synopsys, Inc. (NASDAQ:SNPS)